The resulting large workload requires automated contour propagation from planning CT (pCT) to the rCTs. Consequently, decisions to re-plan are directly based on the propagated contours. Therefore, we investigated whether deformable propagated organs at risk (OARs) contours of head and neck cancer patients can be used for clinical treatment plan evaluation on rCTs.
Results:
The ACs were very similar to the CCs with an average (±SD) DSC for all structures of 0.93 ± 0.07 (range: 0.57-1.00), indicating no or minor corrections required for the majority of contours. The DSC was lower than 0.8 for 10% of the pharyngeal constrictor muscle and 12% of the cricopharyngeal muscle contours, respectively. For all other structures the DSC was larger than 0.9 for 93% of the contours. The average 90th percentile AC to CC contour distance was below the size of an image voxel (0.66 ± 0.25 mm; range: 0.00 -1.50 mm). The dosimetric parameters revealed only small differences between the AC and CC dose values. Only in 3% of all analyzed contours the difference in accumulated dose between the AC and CC was more than 2 Gy. In Figure 1 the fractional ipsilateral parotid gland dose of AC and CC is shown for five representative cases.
Conclusion:
Deformable OARs contour propagation from the planning CT to weekly acquired repeat CTs in the head and neck area resulted in similar contours and dosimetric values compared to the ground truth manually corrected contours. Only smaller contours such as the swallowing muscles, required manual review when used for decision making on replanning. Automatic contour propagation makes it feasible to include more patients in an adaptive radiotherapy schedule. Purpose or Objective: The geometric accuracy of MR-only based RT planning is influenced by several aspects, most of which have been evaluated thoroughly and solutions been provided: differently shaped MR and treatment tables, skin indentations by MR coils, geometrical distortions in MRI, and accuracy of segmentation. This work evaluates whether the body outline as visualized by MRI precisely matches the physical body outline, or whether there is potentially any skin layer that is not visualized by MRI. Correct delineation of the body outline is important because it directly influences attenuation and hence dose delivered to treatment and risk organs.
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Material and Methods:
Standard ultra-sound gel was doped with 10% Gd-contrast agent, and a lump of gel was applied to the thigh of a male volunteer. Two polyethylene foils (50µm and 12µm thickness) were immersed in doped gel in a phantom and located beside the gel on the thigh to serve as a reference. A two-channel surface coil (diameter 7cm) was used to acquire axial images with a 3D T1w-FFE-mDIXON sequence as used for MR-only RT planning in prostate. Images were acquired at standard resolution (1.7mm²x2.5mm) and high resolution (0.5mm²x2mm) in a 200mm²x10mm FOV on a 1.5T scanner (Philips Achieva). Read-out was chosen in LR direction to avoid any water-fat shift perpendicular to the skin.
Results: None of the reconstructed images (TE1, TE2, water, in-phase, opposed-phase) revealed any hypo-intense layer between the outermost MR-visible layer and the gel (c.f. Fig:  thin white arrows) . However, the 50µm PE foil in the phantom was clearly visible in the highly resolved images (bold white arrows), and the 12µm foil was just about visible (bold grey arrows). Initial scans had shown that plain gel generates a much stronger signal than the outer skin layer, so that the gel signal obscures the skin signal, which complicates image interpretation. Doping with 10% contrast agent resulted in a match of signal strength of gel and skin and resolved this. Image interpretation was unambiguous with respect to water-fat shift, since it was chosen parallel to the skin surface in the evaluated region.
Conclusion:
It can be concluded that any MR-invisible skin layer that may be present on top of the outermost MR-visible layer but not be visualized due to lack of free water or other MRI effects has a thickness of less than 20µm. Such a thin layer would have a negligible effect on simulation of attenuation maps and respective dose planning, which is clinically done with a spatial resolution of 4mm. 
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Material and Methods:
Fourteen patients with HNSCC underwent a pCT and T1-weighted MRI in both a diagnostic and treatment position. The GTV was delineated on all images by a single radiation oncologist and intra-observer variability was assessed over 5 patients having been contoured on 3 occasions. GS structures were defined as contours from MRI-RT transposed to pCT using rigid registration. The GS was compared to contours produced by 4 methods: MRI-D transposed to pCT with deformable image registration (DIR) over the whole image (DIR-Whole); MRI-D transposed to pCT with rigid registration or DIR optimised on a 3cm ROI around the GTV (Rigid-ROI and DIR-ROI respectively); and on pCT alone. Registrations were performed with Mirada RTx v1.4 (Mirada Medical, Oxford UK) and 6 contour comparison metrics were calculated with ImSimQA v3.1 (OSL, Shrewsbury UK).
Results: MRI delineation reduced intra-observer variability compared to pCT. DIR-whole resulted in GTVs significantly closer to the GS as determined by multiple positional metrics in comparison with CT-only delineation (normalised results are shown in Figure 1 ). The mean Dice Similarity Coefficient was 0.6 and 0.72 for pCT and DIR-whole respectively with p=0.019. Use of MRI-D with Rigid-ROI or DIR-ROI provided no advantage over CT-only delineation.
Conclusion:
In the absence of dedicated MRI-RT, image registration software can aid the integration of MRI-D into the treatment pathway. MRI-D is most accurately integrated into the radiotherapy planning pathway when contours are transposed to pCT with DIR over the whole patient.
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